Liver Health ECHO Program - NAFLD Staging & Treatment: Effectively Treat & Manage Each Stage of the Condition

Bringing Fatty Liver Disease Prevention & Treatment to Healthcare Providers on the Frontlines

American Liver Foundation created a new Project Echo program for healthcare providers that will bring treatment and prevention best practices for nonalcoholic fatty liver disease (NAFLD)*, to non-liver experts.

The Liver Health ECHO Program is a virtual community of practice developed to equip healthcare providers with the necessary skills to treat and prevent NAFLD among their patients. Within this network, participants will gain support and mentorship, enhance their skills, and connect with leaders in the field all at no cost. This program will provide,

• Structured support in treating NAFLD with practical prevention strategies
• Mentorship from peers and experts in the field, collaborative problem-solving and sharing of resources
• Connection with other primary care providers and allied health professionals across the U.S.

The sessions will be held live via Zoom and will be recorded. There is no cost to participate. The sessions will be held monthly from 12:00 p.m. - 1:00 p.m. ET, dates listed below:

• August 6, 2024 - NAFLD 101: An Overview of the Condition
• September 3, 2024 - NAFLD Screening & Testing: Latest Advancements in Diagnostic Options
• October 1, 2024 - NAFLD Staging & Treatment: Effectively Treat & Manage Each Stage of the Condition
• November 5, 2024 - NAFLD Prevention: Utilizing Health Education to Improve Patient Health
• December 3, 2024 - The Future of NAFLD: Emerging Issues & Resources

The October 1, 2024 session titled NAFLD Staging & Treatment: Effectively Treat & Manage Each Stage of the Condition will be presented by Maya Balakrishnan, MD, MPH, and Adam Buckholz, MD, MS. 

Register now! Click here: https://iecho.org/public/program/PRGM1717177145551LS098XFWSI

*The nomenclature for nonalcoholic fatty liver disease (NAFLD) has recently changed to metabolic dysfunction associated steatotic liver disease (MASLD). Nonalcoholic steatohepatitis (NASH) has been renamed to metabolic dysfunction associated steatohepatitis (MASH). Fatty liver disease is now called steatotic liver disease. Learn more about the nomenclature changes in this video: https://liverfoundation.org/resource-center/videos/new-nomenclature-for-fatty-liver-disease/.

Last updated on October 10th, 2024 at 09:51 am